Risk factors and outcome of COVID-19 in patients with hematological malignanciesJosé Luís Piñana, Anna Sureda, Rodrigo Martino et al.|Experimental Hematology and Oncology|2020Cited by 159
Monitoring treatment with 5-Azacitidine by flow cytometry predicts duration of hematological response in patients with myelodysplastic syndromeDolores Subirá, Dunia de Miguel, Katherina Psarra et al.|Annals of Hematology|2021Cited by 7